新生儿黄疸中茵栀黄口服液与妈咪爱的联合应用疗效分析

李海

（陕西省榆林市神木县第二人民医院，陕西 榆林，719399）

浏览次数：106次 下载次数：353次

摘要：

目的 研究茵栀黄口服液与妈咪爱联合治疗新生儿黄疸的临床效果。方法 选择2014年2月至2015年12月在我院进行诊治的新生儿黄疸100例，随机分为观察组与对照组，每组50 例。对照组患儿进行常规治疗，观察组患儿在对照组基础上 采用茵栀黄口服液联合妈咪爱治疗，比较两组的临床治疗效果，以及胆红素水平日均降低值和平均退黄时间。结果 观察组 治疗总有效率为94.00%（47/50），明显高于对照组的78.00%（39/50）（P<0.05）；观察组患儿的胆红素水平日均降低值和平均 退黄时间分别为（47.13±6.28）μmol/L、（5.03±1.25）d，明显优于对照组的（28.36±5.43）μmol/L、（7.83±1.85）d（P<0.05）。结论 茵栀黄口服液与妈咪爱联合应用可以有效缓解新生儿黄疸患儿的临床症状，缩短黄疸的持续时间，具有较好的治疗效果。

关键词：新生儿黄疸；妈咪爱；茵栀黄口服液

中图分类号：R722.1文献标志码：A文章编号：2096-1413(2017)36-0110-02

Curative effect analysis of combined application of Yinzhihuang oral liquid and Mamiai on neonatal jaundice
LI Hai
(the Second People``s Hospital of Shenmu County in Yulin, Yulin 719399, China)

ABSTRACT: Objective To study the clinical therapeutic effect of Yinzhihuang oral liquid combined with Mamiai in the treatment of neonatal jaundice. Methods One hundred cases with neonatal jaundice treated in our hospital from Feburary 2014 to December 2015 were selected as study objects, and randomly divided into observation group and control group, with 40 cases in each group. The control group was given conventional treatment, while the observation group was treated with combination therapy of Yinzhihuang oral liquid and Mamiai on the basis of the control group. The clinical therapeutic effects, the average daily decrease value of bilirubin and average time of jaundice disappearance were compared between the two groups. Results The total effective rate of the observation group was 94.00% (47/50), which was significantly higher than 78.00% (39/50) of the control group (P<0.05). In the observation group, the average daily decrease value of bilirubin and average time of jaundice disappearance were (47.13±6.28) μmol/L and (5.03±1.25) d, which were significantly better than (28.36±5.43) μmol/L and (7.83±1.85) d in the control group (P<0.05). Conclusion The combination application of Yinzhihuang oral liquid and Mamiai can effectively alleviate clinical symptoms of neonatal jaundice, shorten the duration of jaundice, and has a better therapeutic effect.
KEYWORDS: neonatal jaundice; Mamiai; Yinzhihuang oral liquid

参考文献：
[1] 刘艳龙,刘铁莲.血清白蛋白、非结合胆红素检测在新生儿黄疸中的临床应用价值研究[J].中国实验诊断学,2012,16(6):1120-1121.
[2] 梁静,吴丽杰,郑郑,等.ABO 母儿血型不合孕妇产前应用中药方剂 对新生儿黄疸的影响[J].中日友好医院学报,2011,25(2):84-86.
[3] 王卫平.儿科学[M].8 版.北京:人民卫生出版社,2013:119-120.
[4] 黄安安,徐敏,董敏.催产素产前使用剂量与产妇血清总胆汁酸含量及新生儿黄疸的相关性[J].中国生化药物杂志,2012,33(5):658-660.
[5] 柳文菊,黄娥,谢良才.新生儿黄疸尿液与母乳人巨细胞病毒-DNA 配对检测结果分析[J].中华医院感染学杂志,2012,22(23):5206-5207.
[6] 姚志军,毕仲江,徐莎,等.茵栀黄口服液、贝飞达联合光疗治疗新生 儿黄疸的临床疗效分析[J].现代生物医学进展,2013,13(20):3878-3880.
[7] 张志新,闫利红,王长华,等.金双歧联合茵栀黄口服液、茵栀黄口服 液单药治疗新生儿黄疸的疗效比较[J].求医问药:学术版,2012,10(9):369-369.
[8] 王玉敏.茵栀黄注射液致不良反应49 例报告及相关因素分析[J]. 河北中医,2015,37(4):591-592.
[9] 王亚琼,陈卫,钟水生,等.金银花清热解毒作用的血清代谢组学研 究[J].中药材,2016,39(5):1129-1133.
[10] 李邹金,冷秋文,唐清萍,等.妈咪爱散联合茵栀黄颗粒、思密达散 干预新生儿黄疸的临床疗效观察[J].中国妇幼保健,2012,27(8):1239-1240.
[11] 章历红,王丽莉,赵灵,等.妈咪爱联合蓝光照射早期干预对改善新 生儿黄疸和生长发育的临床评估[J].中国妇幼保健,2015,30(23):4036-4038.
[12] 张文旻.茵栀黄联合微生态制剂治疗新生儿黄疸的临床效果及 对免疫功能的影响[J].实用临床医学,2013,14(10):86-87.
[13] 贾金华.茵栀黄联合妈咪爱治疗新生儿黄疸的临床疗效及对免 疫功能及体质量的影响[J].中国医药指南,2015,13(21):237-238.